News Daily News AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care L.A. McKeown May 17, 2024
News Conference News EAS 2021 For High-Risk Patients Getting Evolocumab in Europe, Other Meds Fall Short Michael O'Riordan June 03, 2021
News Daily News PAD Patients Undertreated With Statins Despite Elevated CV Risk L.A. McKeown July 13, 2020
News Conference News ACC 2020 VOYAGER PAD: Rivaroxaban Bests Aspirin Alone for Preventing Limb and CV Events L.A. McKeown March 28, 2020
News Conference News ACC 2020 Diabetes May Boost Benefits of COMPASS Dual Antithrombotic Approach Todd Neale March 28, 2020
News Daily News Outcome Differences Between Men and Women With PAD: EUCLID Insights L.A. McKeown February 11, 2020
News Daily News Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES Michael O'Riordan August 26, 2019
News Conference News VIVA 2018 Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease L.A. McKeown November 15, 2018
Presentation TCT 2017 TCT 92: Polyvascular Disease and Risk of Major Cardiovascular Events in Peripheral Artery Disease - Insights From EUCLID Presenter: Kurt Huber, Jamil Abdalla Saad, Antonio Gutierrez, MD October 31, 2017
News Daily News ACC/AHA ‘Very High Risk’ Criteria Only Modestly Predict Recurrent Events Michael O'Riordan April 04, 2017
News Daily News Dietary Habits May Aid Secondary Prevention in Patients With Stable CHD Caitlin E. Cox April 25, 2016
News Daily News Polyvascular Disease Worsens Long-term Prognosis for Older NSTEMI Patients July 03, 2012
News Daily News La Enfermedad Polivascular Empeora el Pronóstico a Largo Plazo de Pacientes NSTEMI July 03, 2012